AU2001262011A1 - A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component - Google Patents
A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active componentInfo
- Publication number
- AU2001262011A1 AU2001262011A1 AU2001262011A AU6201101A AU2001262011A1 AU 2001262011 A1 AU2001262011 A1 AU 2001262011A1 AU 2001262011 A AU2001262011 A AU 2001262011A AU 6201101 A AU6201101 A AU 6201101A AU 2001262011 A1 AU2001262011 A1 AU 2001262011A1
- Authority
- AU
- Australia
- Prior art keywords
- complex
- polysaccharides
- preparation
- pharmaceutical composition
- active component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00115400 | 2000-04-17 | ||
CN00115400 | 2000-04-17 | ||
CN00115752 | 2000-05-18 | ||
CN00115752A CN1095472C (en) | 2000-04-17 | 2000-05-18 | Folica acid-polysaccharide composite and its preparation and medical composition with the composite as active component |
PCT/CN2001/000555 WO2001079302A1 (en) | 2000-04-17 | 2001-04-16 | A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001262011A1 true AU2001262011A1 (en) | 2001-10-30 |
Family
ID=25739437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001262011A Abandoned AU2001262011A1 (en) | 2000-04-17 | 2001-04-16 | A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component |
Country Status (7)
Country | Link |
---|---|
US (1) | US7005426B2 (en) |
EP (1) | EP1291362A4 (en) |
JP (1) | JP2003533555A (en) |
CN (1) | CN1095472C (en) |
AU (1) | AU2001262011A1 (en) |
CA (1) | CA2407065A1 (en) |
WO (1) | WO2001079302A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008515915A (en) * | 2004-10-07 | 2008-05-15 | エモリー ユニバーシティー | Multifunctional nanoparticle conjugates and their use |
US20070042970A1 (en) * | 2005-08-22 | 2007-02-22 | Chemical Soft R&D Inc. | Folate-modified cholesterol-bearing pullulan as a drug carrier |
US8394391B2 (en) * | 2007-08-31 | 2013-03-12 | University Of Utah Research Foundation | Drug delivery vehicle that mimics viral properties |
CN101235102B (en) * | 2008-02-18 | 2010-11-03 | 南昌航空大学 | Method for preparing folic acid coupling hydroxypropyl chitosan nano particles |
CN104116755A (en) * | 2014-06-19 | 2014-10-29 | 无限极(中国)有限公司 | Ganoderma lucidum, wolfberry and rhizoma polygonati compound polysaccharide with tumor microenvironment regulation function as well as preparation method and application thereof |
CN104491873A (en) * | 2014-12-10 | 2015-04-08 | 江南大学 | Preparation method of heparin-folic acid conjugate with low anticoagulant activity and tumor targeting property |
BR112019002495A2 (en) | 2016-08-12 | 2019-05-14 | L.E.A.F. Holdings Group Llc | polyglutamate antifolates and their uses |
WO2019157129A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
CA3090494A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pemetrexed and uses thereof |
US20210346381A1 (en) * | 2018-02-07 | 2021-11-11 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated tetrahydrofolates and uses thereof |
CA3090992A1 (en) * | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated tetrahydrofolates and uses thereof |
EP3752157A4 (en) | 2018-02-14 | 2022-07-06 | L.E.A.F Holdings Group LLC | Gamma polyglutamated lometrexol and uses thereof |
CN109456330B (en) * | 2018-11-26 | 2021-05-14 | 连云港德洋化工有限公司 | Folic acid stable compound and its preparing method |
CN110357981B (en) * | 2019-07-22 | 2023-08-04 | 福建亿彤生物科技有限公司 | Polysaccharide carrier with endocytosis mediated function and preparation method thereof |
KR102619293B1 (en) * | 2021-01-14 | 2023-12-29 | 주식회사 엔바이오스 | Anti cancer composition comprising SP-FA conjugates as active ingredient |
CN113087813B (en) * | 2021-03-17 | 2021-11-02 | 广州芊亮科技有限公司 | Tea bran extraction process |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1767499A1 (en) * | 1968-05-16 | 1971-09-09 | Merck Patent Gmbh | Process for the production of durable vitamin preparations |
GB1541435A (en) * | 1975-02-04 | 1979-02-28 | Searle & Co | Immunological materials |
JPS59152327A (en) * | 1983-02-16 | 1984-08-31 | Otsuka Pharmaceut Co Ltd | Stabilized vitamin preparation |
JPS61207237A (en) * | 1985-03-11 | 1986-09-13 | Nippon Soken Inc | Rotary car seat |
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US4857505A (en) * | 1987-03-09 | 1989-08-15 | American Cyanamid Company | Sustained release compositions for parenteral administration and their use |
DE3744068A1 (en) * | 1987-12-24 | 1989-07-06 | Boehringer Mannheim Gmbh | METHOD FOR THE PRODUCTION OF A HAPTENIZED POLYSACCHARIDE MATRIX |
DE3904119A1 (en) * | 1989-02-11 | 1990-08-16 | Hoechst Ag | POLYMER FIXED METHOTREXATE, METHOD FOR PRODUCTION AND USE |
US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
DE563249T1 (en) * | 1990-12-19 | 1994-03-03 | Advanced Magnetics Inc | TARGETING THERAPEUTIC AGENTS BY USING POLYSACCHARIDES. |
CH684644A5 (en) * | 1992-07-13 | 1994-11-15 | Eprova Ag | 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds. |
US5547668A (en) * | 1995-05-05 | 1996-08-20 | The Board Of Trustees Of The University Of Illinois | Conjugates of folate anti-effector cell antibodies |
-
2000
- 2000-05-18 CN CN00115752A patent/CN1095472C/en not_active Expired - Fee Related
-
2001
- 2001-04-16 CA CA002407065A patent/CA2407065A1/en not_active Abandoned
- 2001-04-16 WO PCT/CN2001/000555 patent/WO2001079302A1/en not_active Application Discontinuation
- 2001-04-16 EP EP01935921A patent/EP1291362A4/en not_active Withdrawn
- 2001-04-16 JP JP2001576896A patent/JP2003533555A/en active Pending
- 2001-04-16 AU AU2001262011A patent/AU2001262011A1/en not_active Abandoned
-
2002
- 2002-10-17 US US10/274,854 patent/US7005426B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1291362A4 (en) | 2005-02-02 |
CN1095472C (en) | 2002-12-04 |
EP1291362A1 (en) | 2003-03-12 |
US7005426B2 (en) | 2006-02-28 |
WO2001079302A1 (en) | 2001-10-25 |
CN1287127A (en) | 2001-03-14 |
US20030125302A1 (en) | 2003-07-03 |
CA2407065A1 (en) | 2001-10-25 |
JP2003533555A (en) | 2003-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001237526A1 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
AU2001262318A1 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
AU2001262011A1 (en) | A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component | |
AU2001237525A1 (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
ZA200301813B (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
AU2002213977A1 (en) | Novel anticholinergics, method for the production thereof and use thereof as medicaments | |
AU2002342968A1 (en) | Fatty acid compounds, preparation and uses thereof | |
AU2001278771A1 (en) | Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient | |
AU2002352334A1 (en) | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | |
AU2682401A (en) | Flavonoid drug and dosage form, its production and use | |
AU2002233463A1 (en) | Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use | |
AU2001277602A1 (en) | Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same | |
ZA200109602B (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same. | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
AU2001263835A1 (en) | Haemostatically active preparation containing vWF and method for the production thereof | |
AU3560601A (en) | Novel isoquinoline derivatives, preparation method and pharmaceutical compositions containing them | |
AU2001269252A1 (en) | Alcohol-free base for aqueous perfume composition, and alcohol-free aqueous perfume composition comprising same | |
AU2003224482A1 (en) | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same | |
AU2000254308A1 (en) | Pyrazolopyrimidinone derivatives, process for their preparation and their use | |
AU2001254812A1 (en) | 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations | |
AU4884701A (en) | Malonanilic acid derivatives, medicinal compositions containing the same and usethereof | |
AU2001293697A1 (en) | N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives | |
AU2002222026A1 (en) | Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same | |
AU2001250625A1 (en) | 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them | |
AU2001241067A1 (en) | Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient |